Search results
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 8 hours agoVertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion...
Vertex’s stock climbs as non-opioid pain treatment advances
Market Watch· 1 day agoVertex Pharmaceuticals shares gained ground early Thursday after the company signaled progress in...
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
Motley Fool via Yahoo Finance· 1 day agoBiotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) continues to grab headlines. Over the past six...
William Blair Analysts Raise Earnings Estimates for Vertex Pharmaceuticals Incorporated...
ETF DAILY NEWS· 15 hours agoVertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Analysts at William Blair upped their Q1 2024 earnings estimates for shares of Vertex ...
Vertex starts rolling submission for non-opioid pain therapy
Seeking Alpha· 1 day agoVertex Pharmaceuticals (VRTX) stock gains as it begins marketing submission for its non-opioid pain...
Mackenzie Financial Corp Has $35.33 Million Stock Position in Vertex Pharmaceuticals Incorporated...
ETF DAILY NEWS· 1 day agoMackenzie Financial Corp lifted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 4.6% during the 4th quarter, according to the ...
Vertex begins bid for US approval of non-opioid painkiller
BioPharma Dive via Yahoo Finance· 1 day agoVertex Pharmaceuticals is vying for approval of an experimental and closely watched painkiller that...
Vertex inches closer to acute pain market with FDA application acceptance
FierceBiotech· 1 day agoVertex Pharmaceuticals has inched closer to bringing a new, non-opioid med to the blockbuster pain...
Arc’teryx Vertex Alpine GTX approach shoe review: style and performance on above-the-treeline...
Advnture via Yahoo News· 1 day agoArc’teryx Vertex Alpine GTX approach shoe. Meet the reviewer Arc’teryxVertex Alpine GTX: first...
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks via Yahoo Finance· 3 days agoThe most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $394.17,...